NASDAQ:CDT • US20678X4034
The current stock price of CDT is 1.04 USD. In the past month the price decreased by -25.71%. In the past year, price decreased by -99.47%.
ChartMill assigns a fundamental rating of 1 / 10 to CDT. CDT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months CDT reported a non-GAAP Earnings per Share(EPS) of -473.65. The EPS increased by 47.46% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -242.03% | ||
| ROE | -483.82% | ||
| Debt/Equity | 0 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 20.54 | 198.063B | ||
| DHR | DANAHER CORP | 25.31 | 155.383B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 134.01 | 49.722B | ||
| A | AGILENT TECHNOLOGIES INC | 20.63 | 36.543B | ||
| IQV | IQVIA HOLDINGS INC | 12.91 | 30.05B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 29.37 | 28.313B | ||
| WAT | WATERS CORP | 22.11 | 19.597B | ||
| ILMN | ILLUMINA INC | 22.1 | 17.783B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.04 | 17.709B | ||
| MEDP | MEDPACE HOLDINGS INC | 24.75 | 11.942B |
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company is headquartered in Naples Florida, Florida and currently employs 6 full-time employees. The company went IPO on 2022-02-03. Through advanced co-crystallization and solidform technologies developed at its Cambridge facility, it is engaged in improving drug properties and has helped in extending the patent life of certain drugs by up to 20 years. Its pipeline includes candidates targeting inflammatory and autoimmune disorders, as well as idiopathic male infertility, dermatology and animal health. The company applies proprietary algorithms utilizing AI-powered disease mapping to identify novel repurposing opportunities against a database of over 800 disease signatures. In addition, the Company has initiated pre-clinical in-vitro models to explore new indications, guided by AI-insights without human intervention.
CDT EQUITY INC
4851 Tamiami Trail North, Suite 200
Naples Florida FLORIDA US
Employees: 6
Phone: 13026587581
CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company is headquartered in Naples Florida, Florida and currently employs 6 full-time employees. The company went IPO on 2022-02-03. Through advanced co-crystallization and solidform technologies developed at its Cambridge facility, it is engaged in improving drug properties and has helped in extending the patent life of certain drugs by up to 20 years. Its pipeline includes candidates targeting inflammatory and autoimmune disorders, as well as idiopathic male infertility, dermatology and animal health. The company applies proprietary algorithms utilizing AI-powered disease mapping to identify novel repurposing opportunities against a database of over 800 disease signatures. In addition, the Company has initiated pre-clinical in-vitro models to explore new indications, guided by AI-insights without human intervention.
The current stock price of CDT is 1.04 USD. The price decreased by -5.45% in the last trading session.
CDT does not pay a dividend.
CDT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
CDT EQUITY INC (CDT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-473.65).
CDT EQUITY INC (CDT) currently has 6 employees.